Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Tryptamine Therapeutics has released ...
Four of up to 10 patients successfully administered with Tryptamine’s oral psilocybin formula TRP-8802 in phase 2a trial to treat IBS Trial held at Massachusetts General Hospital, marking first time ...
The trial, titled "A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of a Single Intravenous (IV) Infusion of TRP-8803 (psilocin) in Healthy Adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results